Full Text
The Introduction Of Biosimilar Monoclonal Antibodies Into Developed Markets- What Are Payers Concerned About?

Abstract

Authors

N.P.S. Sewak C. Whitcher I. Neophytou

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×